Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON35520
NL-OMON35520
Recruiting
Not Applicable

Measuring Athlete's Risk of Cardiovascular events - MARC

Meander Medisch Centrum0 sites300 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsatherosclerosiscoronary artery disease1001108210003216

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
atherosclerosis
Sponsor
Meander Medisch Centrum
Enrollment
300
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
Meander Medisch Centrum

Eligibility Criteria

Inclusion Criteria

  • •Male athletes aged 45 years or older age, asymptomatic for heart disease who undergo exercise testing as part of a sports medical evaluation, who are able to understand the study procedure and objectives

Exclusion Criteria

  • •Known cardiovascular disease
  • •Rhythm other than sinusrhythm
  • •Pacemaker rhythm
  • •Not able to hold breath for 25 sec.
  • •Asthma/COPD and resting heart rate \> 70/min after intravenous administration with beta blocker)
  • •Iodine\-allergy
  • •Hypertension (Blood pressure \> 200/110 mmHg)
  • •Obesity BMI \>40 kg/m2
  • •Decreased renal function (GFR \<60 mL/min)
  • •Language barrier

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Measuring Athletes’ Risk of Cardiovascular Events - Exercise-Induced Cardiac Troponin Release and CoronaryAtherosclerosis in Amateur Athletes
NL-OMON24615Department of Physiology, Radboudumc60
Completed
Not Applicable
Measuring Athletes* Risk of Cardiovascular Events - Exercise-Induced Cardiac Troponin Release and Coronary Atherosclerosis in Amateur Athletes
NL-OMON49634Radboud Universitair Medisch Centrum60
Not yet recruiting
Not Applicable
Assessment of cardio vascular risk by measurement of carotid intima-media thickness (cIMT) in adult type I Gaucher disease patients.Gaucher disease type Iglucocerebrosidase deficiency10027424
NL-OMON29706Academisch Medisch Centrum140
Active, not recruiting
Phase 1
CREATE. Cardiovascular Risk Evaluation and Attenuation of inflammation by early rosuvastatin TrEatment - CREATE
EUCTR2006-001860-22-ISKarl Andersen
Recruiting
Phase 4
A clinical trial for Heart Disease Risk assessment and treatment of patients with high risk.Health Condition 1: I00-I99- Diseases of the circulatory system
CTRI/2019/04/018723Dr Saurabha Nayak